The identification and treatment of toxic megacolon secondary to pseudomembranous colitis

Dimensions of Critical Care Nursing : DCCN
Megan M Earhart


Toxic megacolon is an infrequently occurring, potentially life-threatening complication of pseudomembranous colitis. Although toxic megacolon may be considered rare, incidence is expected to increase because of the rapidly increased prevalence of pseudomembranous colitis. This article discusses the pathophysiology, clinical manifestation, diagnosis, treatment, and prognosis for toxic megacolon secondary to pseudomembranous colitis. Critical care nurses should be aware of the disease to intervene early and increase the chance of the patient's survival.


Apr 1, 1985·Journal of Clinical Gastroenterology·A J GreensteinA H Aufses
Oct 1, 1995·Diseases of the Colon and Rectum·J L TrudelA N Barkun
Mar 3, 1998·Lancet·S G Sheth, J T LaMont
Mar 21, 1998·The British Journal of Surgery·K SynnottR Quill
Jun 24, 2000·AACN Clinical Issues·C D Levine
Nov 26, 2003·The American Journal of Gastroenterology·S Ian Gan, P L Beck


Oct 27, 2011·Gastroenterology Research and Practice·Nora E BurkartGenevieve B Melton
May 28, 2009·Orvosi hetilap·Anna BazsóZsolt Balogh
May 18, 2016·Journal of Emergency Nursing : JEN : Official Publication of the Emergency Department Nurses Association·Erik Woodhouse
Nov 26, 2003·The American Journal of Gastroenterology·S Ian Gan, P L Beck
Jan 9, 2015·Clinical Microbiology Reviews·Romney M Humphries, Andrea J Linscott
Mar 5, 2014·The American Journal of Drug and Alcohol Abuse·Carlos ZubaranJustin Surjadi

Related Concepts

Antineoplastic Agents
Care of Intensive Care Unit Patient
Diabetes Mellitus, Non-Insulin-Dependent
Clostridium Enterocolitis
Tube Ileostomy
Megacolon, Toxic
Acute Myeloid Leukemia, M1
Nurse's Role

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Related Papers

Revista de gastroenterología de México
E Villanueva-SáenzC Mejía
Diseases of the Colon and Rectum
J L TrudelA N Barkun
Journal of the Formosan Medical Association = Taiwan Yi Zhi
T C TsaiB Hwang
Journal of Clinical Gastroenterology
Loren BermanKurt E Roberts
© 2021 Meta ULC. All rights reserved